DEBDUTTA BHATTACHARYA

Dr. DEBDUTTA BHATTACHARYA

Microbiology & One Health, ICMR-Regional Medical Research Centre, Bhubaneswar, Bhubaneswar, India
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MMManoj Vasant Murhekar
Manoj Vasant Murhekar
TBTarun Bhatnagar
Tarun Bhatnagar
JTJeromie Wesley Vivian Thangaraj
Jeromie Wesley Vivian Thangaraj
VSV. Saravanakumar
V. Saravanakumar
MKMuthusamy Santhosh Kumar
Muthusamy Santhosh Kumar
AVArya Vinod
Arya Vinod
Earlier serosurveys in India revealed seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) of 0.73% in May–June 2020 and 7.1% in August–September 2020. A third serosurvey was conducted between December 2020 and January 2021 to estimate the seroprevalence of SARS-CoV-2 infection among the general population and healthcare workers (HCWs) in India. The third serosurvey was conducted in the same 70 districts as the first and second serosurveys. For each district, at least 400 individuals aged ≥10 years from the general population and 100 HCWs from subdistrict-level health facilities were enrolled. Serum samples from the general population were tested for the presence of immunoglobulin G (IgG) antibodies against the nucleocapsid (N) and spike (S1-RBD) proteins of SARS-CoV-2, whereas serum samples from HCWs were tested for anti-S1-RBD. Weighted seroprevalence adjusted for assay characteristics was estimated. Of the 28,598 serum samples from the general population, 4585 (16%) had IgG antibodies against the N protein, 6647 (23.2%) had IgG antibodies against the S1-RBD protein, and 7436 (26%) had IgG antibodies against either the N protein or the S1-RBD protein. Weighted and assay-characteristic-adjusted seroprevalence against either of the antibodies was 24.1% [95% confidence interval (CI) 23.0–25.3%]. Among 7385 HCWs, the seroprevalence of anti-S1-RBD IgG antibodies was 25.6% (95% CI 23.5–27.8%). Nearly one in four individuals aged ≥10 years from the general population as well as HCWs in India had been exposed to SARS-CoV-2 by December 2020.

1 February 2016 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
KJKiran Jadhav
Kiran Jadhav
DDDinesh Dhamecha
Dinesh Dhamecha
DBDEBDUTTA BHATTACHARYA
DEBDUTTA BHATTACHARYA
MPMrityunjaya Patil
Mrityunjaya Patil

27 June 2011 in Letters in Applied Microbiology
Verified
Journal Article
Closed access
PDF file
DBDEBDUTTA BHATTACHARYA
DEBDUTTA BHATTACHARYA
HBH. Bhattacharjee
H. Bhattacharjee
RTR. Thamizhmani
R. Thamizhmani
DSD.S. Sayi
D.S. Sayi
ABA. P. Bharadwaj
A. P. Bharadwaj
SRS. Roy
S. Roy

29 August 2013 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
DBDEBDUTTA BHATTACHARYA
DEBDUTTA BHATTACHARYA
HBH. Bhattacharya
H. Bhattacharya
RTR. Thamizhmani
R. Thamizhmani
DSD. S. Sayi
D. S. Sayi
RRR. Reesu
R. Reesu
SRS. Roy
S. Roy

2 July 2021 in Infection
Verified
Journal Article
Closed access
PDF file
HCHari Ram Choudhary
Hari Ram Choudhary
DPDebaprasad Parai
Debaprasad Parai
GDGirish Chandra Dash
Girish Chandra Dash
APAnnalisha Peter
Annalisha Peter
SSSubrat Kumar Sahoo
Subrat Kumar Sahoo
DBDEBDUTTA BHATTACHARYA
DEBDUTTA BHATTACHARYA

10 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SPSubrata Kumar Palo
Subrata Kumar Palo
Shubhankar DubeyShubhankar Dubey
Shubhankar Dubey
SNsapna negi
sapna negi
MSMili Roopchand Sahay
Mili Roopchand Sahay
KPKripalini Patel
Kripalini Patel
SPSanghamitra Pati
Sanghamitra Pati
Introduction: Ensuring accessible and quality health care for women and children is an existing challenge, which is further exacerbated during pandemics. There is a knowledge gap about the effect of pandemics on maternal, newborn, and child well-being. This systematic review was conducted to study maternal and child health (MCH) services utilization during pandemics (Zika, Ebola, and COVID-19) and the effectiveness of various interventions undertaken for ensuring utilization of MCH services. Methodology: A systematic and comprehensive search was conducted in MEDLINE/PubMed, Cochrane CENTRAL, Embase, Epistemonikos, ScienceDirect, and Google Scholar. Of 5643 citations, 60 potential studies were finally included for analysis. The included studies were appraised using JBI Critical appraisal tools. Study selection and data extraction were done independently and in duplicate. Findings are presented narratively based on the RMNCHA framework by World Health Organization (WHO). Results: Maternal and child health services such as antenatal care (ANC) visits, institutional deliveries, immunization uptake, were greatly affected during a pandemic situation. Innovative approaches in form of health care services through virtual consultation, patient triaging, developing dedicated COVID maternity centers and maternity schools were implemented in different places for ensuring continuity of MCH care during pandemics. None of the studies reported the effectiveness of these interventions during pandemic-related health emergencies. Conclusion: The findings suggest that during pandemics, MCH care utilization often gets affected. Many innovative interventions were adopted to ensure MCH services. However, they lack evidence about their effectiveness. It is critically important to implement evidence-based appropriate interventions for better MCH care utilization.